Regulatory approval supports Laurentis’s program to produce the medical isotope Molybdenum-99 in Ontario for BWXT Medical
One of the most prevalently used diagnostic imaging agents in nuclear medicine, helping to detect illnesses like cancer and heart disease Clarington, Ontario – A new program, led by Laurentis Energy Partners and BWXT Medical Ltd. (BWXT Medical), to produce the